MedPath

EURODEVELOPMENTAL OUTCOME OF HIGH RISK NEONATES

Not Applicable
Conditions
Health Condition 1: F900- Attention-deficit hyperactivity disorder, predominantly inattentive type
Registration Number
CTRI/2023/08/055981
Lead Sponsor
ot applicable
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

o High risk babies discharged from Neonatal intensive care unit.

o Patients of babies giving consent for the Study.

Exclusion Criteria

o Babies born with gross Congenital Malformations and syndromes

o Drop outs and failure to follow up from the study.[if followed less than three visits out of four visits]

o Parents not giving consent for the study.

o Babies with major congenital heart diseases

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To study prevalence of neurodevelopmental delay of high risk babies. <br/ ><br> <br/ ><br>2.To study neurodevelopmental outcome in relation to gestational age at birth. <br/ ><br>Timepoint: 2 years <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
3.To study neurodevelopmental outcome in relation to birth weight. <br/ ><br> <br/ ><br>4.To identify different etiological factors and its association with neurodevelopmental outcome in different domains. <br/ ><br>Timepoint: 1,3,6,12 months
© Copyright 2025. All Rights Reserved by MedPath